News and Announcements
Bluechiip – Share Purchase Plan
- Published November 21, 2012 1:32PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Bluechiip Limited (“Bluechiip” or “Company”) is pleased to announce that following the successful completion of its $1.5 million placement to institutional and sophisticated investors, it will offer eligible shareholders the opportunity to participate in a Share Purchase Plan (“SPP”). The Company has secured underwriting for the SPP to the amount of $0.5 million with Baillieu Holst Limited.
The SPP entitles eligible shareholders to apply for up to 75,000 fully paid ordinary shares at $0.20 per share for a maximum investment of $15,000 worth of fully paid ordinary shares in the Company, without incurring brokerage or other transaction costs.
To read a full Share Purchase Plan please download the attached document below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
